deaths from tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Zepbound, Eli Lilly (LLY) Weight-Loss

The flashy television ads for GLP-1 medications are everywhere part of a massive effort to expand the use of these diabetes drugs as mainstream weight loss drugs

Offers a bioavailable form of glutathione

A 28.7% average weight loss at 68 weeks coupled with transformative improvements in knee osteoarthritis pain, cardiovascular risk markers, and metabolic health represents a genuine advance in obesity treatment

Amino Asylum vs Swiss Chems Swiss Chems is a big fish in the pond of research chemicals

This imposes an implicit responsibility on scientists to maintain the highest standards of rigor in their methodological approaches